Bicycle Radionuclide Conjugates Targeting Novel Antigens for Radioisotope Delivery into Solid Tumors
Time: 3:30 pm
day: Conference Day One
Details:
- Outlining the proprietary Bicycle® screening platform can identify novel peptidic binders to complex targets that lack pre-existing peptide-based ligands and then convert these into high affinity and selective Bicycle® molecules
- Revealing development of Bicycle radionuclide conjugates (BRCs) targeting MT1-MMP and EphA2
- Sharing preclinical data from proteins that are widely expressed in a variety of cancers with high unmet medical need
